Format

Send to

Choose Destination

See 1 citation found by title matching your search:

Mol Pharm. 2014 May 5;11(5):1575-82. doi: 10.1021/mp400740c. Epub 2014 Apr 18.

In vivo performance of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile acid transport.

Author information

1
Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy , Baltimore, Maryland 21230, United States.

Abstract

A novel trifluorinated cholic acid derivative, CA-lys-TFA, was designed and synthesized for use as a tool to measure bile acid transport noninvasively using magnetic resonance imaging (MRI). In the present study, the in vivo performance of CA-lys-TFA for measuring bile acid transport by MRI was investigated in mice. Gallbladder CA-lys-TFA content was quantified using MRI and liquid chromatography/tandem mass spectrometry. Results in wild-type (WT) C57BL/6J mice were compared to those in mice lacking expression of Asbt, the ileal bile acid transporter. (19)F signals emanating from the gallbladders of WT mice 7 h after oral gavage with 150 mg/kg CA-lys-TFA were reproducibly detected by MRI. Asbt-deficient mice administered the same dose had undetectable (19)F signals by MRI, and gallbladder bile CA-lys-TFA levels were 30-fold lower compared to WT animals. To our knowledge, this represents the first report of in vivo imaging of an orally absorbed drug using (19)F MRI. Fluorinated bile acid analogues have potential as tools to measure and detect abnormal bile acid transport by MRI.

PMID:
24708306
PMCID:
PMC4018118
DOI:
10.1021/mp400740c
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for American Chemical Society Icon for PubMed Central
Loading ...
Support Center